Suspension Culture Vessel for Homogeneous iPS Cell Reprogramming
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for culturing induced pluripotent stem cells (iPS cells) are inefficient and face challenges such as immunorejection and ethical concerns, necessitating improved devices and methods for their culturing and induction.
Innovation Solution
A cell treatment device comprising a factor introducing device and a suspension culture vessel that introduces a pluripotency inducing factor into cells, allowing reprogramming and amplification within a semipermeable membrane system with controlled agitation and medium exchange.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If embryonic stem cells are used for transplantation therapy, then therapeutic potential is achieved, but immunorejection and ethical problems occur
Solution Approach 1:
The invention segments the stem cell source problem by creating induced pluripotent stem cells (iPS cells) from patient-specific somatic cells through introduction of reprogramming factors (OCT3/4, KLF4, c-MYC, SOX2). This segmentation allows obtaining therapeutic stem cells without using embryonic cells, thereby avoiding immunorejection and ethical issues while maintaining therapeutic potential
Solution Approach 2:
The invention uses reprogramming factors as intermediaries to transform somatic cells into pluripotent stem cells. These factors act as mediators that enable cell reprogramming without direct use of embryonic cells, thus resolving the contradiction between therapeutic need and ethical/immunological constraints
2Productivity
If conventional adhesion culture methods are used for iPS cells, then cell growth is maintained, but culture efficiency and homogeneity deteriorate
Solution Approach 1:
The invention inverts the conventional adhesion culture approach by using suspension culture where cells grow in non-adherent conditions. This inversion maintains cell homogeneity and prevents differentiation while improving culture efficiency through better nutrient distribution and waste removal
Solution Approach 2:
The invention changes the culture parameter from adhesion-based to suspension-based culture, and introduces controlled agitation parameters to maintain cell homogeneity. These parameter changes improve both productivity and cell composition stability simultaneously
3Ease of operation
If manual culture operations are performed, then operational flexibility is maintained, but time consumption and labor intensity increase
Solution Approach 1:
The invention implements automated culture systems that perform suspension culture operations autonomously. The system self-manages cell culture, medium exchange, and agitation control, eliminating manual intervention while maintaining operational flexibility through programmable parameters
Solution Approach 2:
The invention replaces manual mechanical operations with automated control systems. The drive unit automatically controls agitation speed and medium flow, substituting human-operated mechanical processes with automated mechanisms that reduce time consumption while preserving operational adaptability
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables efficient reprogramming and amplification of iPS cells, maintaining clonality and homogeneity while minimizing ethical issues and immunorejection, facilitating their use in therapeutic applications.
Implementation Method 1
a semipermeable membrane in which the inducing factor-introduced cells and culture medium are placed
Implementation Method 2
The drive unit in this cell treatment device may rotate the agitating member by magnetic force
Data Source
AI summary
This cell treatment device is provided with: a factor introduction device 30 for introducing a pluripotent induction factor into cells so as to prepare induction factor-introduced cells; and a reprogramming suspension culture vessel for culturing the induction factor-introduced cells that have been prepared by the factor introduction device 30.